CGEM
Cullinan Therapeutics, Inc.Company with tickers: CGEM
Market Cap
$1.13B
Shares Outstanding
61,458,046
CIK
1789972
CUSIP
230031106
13F Activity (30d)
1 filings
1 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-16 | — | |
| 8-K | 2026-06-10 | — | |
| 8-K | 2026-06-08 | 2026-06-06 | |
| 8-K | 2026-05-18 | — | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-28 | 2026-04-27 | |
| 8-K | 2026-03-10 | — | |
| 10-K | 2026-03-10 | 2025-12-31 | |
| 8-K | 2026-01-08 | — | |
| 8-K | 2025-12-08 | — | |
| 8-K | 2025-11-21 | 2025-11-18 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-09-04 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-12 | — | |
| 8-K | 2025-06-04 | — | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| DEF 14A | 2025-04-25 | 2025-04-24 | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-29 | 2025-01-28 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-10-16 | — | |
| 8-K | 2024-09-17 | — | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-06-27 | 2024-06-26 | |
| 8-K | 2024-06-03 | 2024-06-01 | |
| 8-K | 2024-05-23 | — | |
| DEF 14A | 2024-05-16 | 2024-06-26 | |
| 8-K | 2024-05-15 | 2024-05-09 | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 8-K | 2024-04-29 | — | |
| 8-K | 2024-04-16 | 2024-04-15 | |
| 8-K | 2024-03-14 | — | |
| 10-K | 2024-03-14 | 2023-12-31 | |
| 8-K/A | 2024-01-08 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-11-08 | — | |
| 10-Q | 2023-11-08 | 2023-09-30 | |
| 10-Q | 2023-08-10 | 2023-06-30 | |
| 8-K | 2023-08-10 | — | |
| 8-K | 2023-06-14 | 2023-06-08 | |
| 8-K | 2023-05-25 | — |
Showing 1–50 of 90 filings